These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19619717)

  • 21. Diagnostic and Therapeutic Challenges.
    Casalino G; McAvoy C; Moutray T; Chakravarthy U; Dolz-Marco R; Freund KB
    Retina; 2017 Feb; 37(2):405-408. PubMed ID: 27437998
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination therapy using the small interfering RNA bevasiranib.
    Singerman L
    Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uveitis as a presenting feature of autoimmune hepatitis.
    Romanelli RG; Almerigogna F
    Am J Ophthalmol; 2009 Aug; 148(2):318-9; author reply 319-20. PubMed ID: 19619722
    [No Abstract]   [Full Text] [Related]  

  • 25. Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension.
    Teng CC; Chin KJ; Finger PT
    Br J Ophthalmol; 2009 Jun; 93(6):837-8. PubMed ID: 19471005
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Lüke J; Peters S; Wirtz N; Yörük E; Lüke C; Bartz-Schmidt KU; Grisanti S; Szurman P
    Br J Ophthalmol; 2009 Oct; 93(10):1396-400. PubMed ID: 19628500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why do tumors become resistant to antiangiogenesis drugs?
    Schmidt C
    J Natl Cancer Inst; 2009 Nov; 101(22):1530-2. PubMed ID: 19880813
    [No Abstract]   [Full Text] [Related]  

  • 28. TARGETING THE SUPRACHOROIDAL SPACE: IN TREATING NONINFECTIOUS UVEITIC MACULAR EDEMA.
    Retina; 2022 Dec; 42(Suppl 1):S1-S16. PubMed ID: 36394901
    [No Abstract]   [Full Text] [Related]  

  • 29. Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedema.
    Braithwaite T; Davis N; Galloway J
    Eye (Lond); 2019 Dec; 33(12):1830-1832. PubMed ID: 31189993
    [No Abstract]   [Full Text] [Related]  

  • 30. Glaucoma as a possible risk factor for the development of pseudophakic cystoid macular edema.
    Feibel RM
    J Cataract Refract Surg; 2008 May; 34(5):717-8; author reply 718. PubMed ID: 18471614
    [No Abstract]   [Full Text] [Related]  

  • 31. Can we be more objective in determining the response to treatment in uveitis patients aside from recording anterior chamber reaction?
    Akduman L
    Ocul Immunol Inflamm; 2009; 17(4):265-6. PubMed ID: 19657980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Uparkar M; Bhende M
    Retina; 2009; 29(10):1549; author reply 1549-50. PubMed ID: 19898197
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravitreal steroids for macular edema.
    Grosso A; Panico C
    Surv Ophthalmol; 2009; 54(3):426; author reply 426-7. PubMed ID: 19422970
    [No Abstract]   [Full Text] [Related]  

  • 34. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 35. [Angiogenesis inhibitors and radiation therapy: from biology to clinical practice].
    Mazeron R; Azria D; Deutsch E
    Cancer Radiother; 2009 Oct; 13(6-7):568-73. PubMed ID: 19695932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfused, but not leaking.
    Prenner JL; Kaiser R; Chang TS
    Ophthalmology; 2009 Aug; 116(8):1590, 1590.e1-2. PubMed ID: 19651318
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetic macular edema.
    Narula R; Agarwal M; Chaudhary SP; Shroff C
    Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebrovascular accidents and ranibizumab.
    Moorthy S; Cheung N
    Ophthalmology; 2009 Sep; 116(9):1834-5; author reply 1835. PubMed ID: 19729107
    [No Abstract]   [Full Text] [Related]  

  • 39. Sudden visual loss in a child with juvenile idiopathic arthritis-related uveitis.
    Zannin ME; Martini G; Buscain I; Cermàkovà I; Suppiej A; Manara R; Zulian F
    Br J Ophthalmol; 2009 Mar; 93(3):282-3, 417. PubMed ID: 19244028
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of laser photocoagulation in clinically significant macular edema with focal versus diffuse parafoveal thickening on optical coherence tomography.
    Barkmeier AJ; Nicholson BP; Akduman L
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):472-9. PubMed ID: 19772271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.